These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31709843)

  • 1. Myelofibrosis: best practices, controversies and 2019 update.
    Cruz NM; Gergis U; Silver RT
    Expert Rev Hematol; 2020 Jan; 13(1):71-84. PubMed ID: 31709843
    [No Abstract]   [Full Text] [Related]  

  • 2. Stem cell transplant for the treatment of myelofibrosis.
    Mannelli L; Guglielmelli P; Vannucchi AM
    Expert Rev Hematol; 2020 Apr; 13(4):363-374. PubMed ID: 32077336
    [No Abstract]   [Full Text] [Related]  

  • 3. Application of Stem Cell Therapy in Myelofibrosis.
    Davidson MB; Gupta V
    Hematol Oncol Clin North Am; 2021 Apr; 35(2):391-407. PubMed ID: 33641876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European wide survey on allogeneic haematopoietic cell transplantation practice for myelofibrosis on behalf of the EBMT chronic malignancies working party.
    McLornan DP; Sirait T; Hernández-Boluda JC; Czerw T; Hayden P; Yakoub-Agha I
    Curr Res Transl Med; 2021 Jan; 69(1):103267. PubMed ID: 33069640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic risk models for transplant decision-making in myelofibrosis.
    Hernández-Boluda JC; Pereira A; Correa JG; Alvarez-Larrán A; Ferrer-Marín F; Raya JM; Martínez-López J; Velez P; Pérez-Encinas M; Estrada N; García-Gutiérrez V; Fox ML; Payer A; Kerguelen A; Cuevas B; Durán MA; Ramírez MJ; Gómez-Casares MT; Mata-Vázquez MI; Mora E; Gómez M; Cervantes F
    Ann Hematol; 2018 May; 97(5):813-820. PubMed ID: 29396714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem cell transplant overcomes the adverse survival effect of very high risk and unfavorable karyotype in myelofibrosis.
    Tefferi A; Partain DK; Palmer JM; Slack JL; Roy V; Hogan WJ; Litzow ML; Ketterling RP; Patnaik MM
    Am J Hematol; 2018 May; 93(5):649-654. PubMed ID: 29388258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transplantation algorithm for myelofibrosis in 2022 and beyond.
    Hernández-Boluda JC; Czerw T
    Best Pract Res Clin Haematol; 2022 Jun; 35(2):101369. PubMed ID: 36333063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic stem cell transplantation for myelofibrosis: where are we now?
    Fleischman AG; Maziarz RT
    Curr Opin Hematol; 2013 Mar; 20(2):130-6. PubMed ID: 23314844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolving understanding of prognosis in post-essential thrombocythemia myelofibrosis and post-polycythemia vera myelofibrosis vs primary myelofibrosis.
    Masarova L; Verstovsek S
    Clin Adv Hematol Oncol; 2019 May; 17(5):299-307. PubMed ID: 31188809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allogeneic haematopoietic stem cell transplantation for primary myelofibrosis and myelofibrosis evolved from other myeloproliferative neoplasms.
    Tamari R; Castro-Malaspina H
    Curr Opin Hematol; 2015 Mar; 22(2):184-90. PubMed ID: 25635756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controversies and dilemmas in allogeneic transplantation for myelofibrosis.
    Shanavas M; Gupta V
    Best Pract Res Clin Haematol; 2014 Jun; 27(2):165-74. PubMed ID: 25189727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?
    Lestang E; Peterlin P; Le Bris Y; Dubruille V; Delaunay J; Godon C; Theisen O; Blin N; Mahe B; Gastinne T; Garnier A; Touzeau C; Voldoire M; Bene MC; Le Gouill S; Milpied N; Mohty M; Moreau P; Guillaume T; Chevallier P
    Eur J Haematol; 2017 Jul; 99(1):60-69. PubMed ID: 28370306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-thymocyte globulin-induced hyperbilirubinemia in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation.
    Ecsedi M; Schmohl J; Zeiser R; Drexler B; Halter J; Medinger M; Duyster J; Kanz L; Passweg J; Finke J; Bethge W; Lengerke C
    Ann Hematol; 2016 Oct; 95(10):1627-36. PubMed ID: 27480090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors for early hepatotoxicity and its impact on survival in patients with myelofibrosis undergoing allogeneic hematopoietic cell transplantation.
    Wong KM; Atenafu EG; Kim D; Kuruvilla J; Lipton JH; Messner H; Gupta V
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1589-99. PubMed ID: 22531490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Perspectives Regarding Allogeneic Bone Marrow Transplantation in Myelofibrosis.
    Palmer J; Scherber R; Girardo M; Geyer H; Kosiorek H; Dueck A; Jain T; Mesa R
    Biol Blood Marrow Transplant; 2019 Feb; 25(2):398-402. PubMed ID: 30292010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen.
    Ali H; Aldoss I; Yang D; Mokhtari S; Khaled S; Aribi A; Afkhami M; Al Malki MM; Cao T; Mei M; O'Donnell M; Salhotra A; Pullarkat V; Yang L; Stein AS; Marcucci G; Forman SJ; Nakamura R; Pillai R; Snyder D
    Blood Adv; 2019 Jan; 3(1):83-95. PubMed ID: 30622146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.
    Schmohl JU; Groh C; Faul C; Vogel W; Möhle R; Wirths S; Schneidawind D; Kanz L; Bethge WA
    Ann Hematol; 2016 May; 95(6):973-83. PubMed ID: 27021303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management.
    Tefferi A
    Am J Hematol; 2011 Dec; 86(12):1017-26. PubMed ID: 22086865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic Cell Transplantation for Myelofibrosis: the Dynamic International Prognostic Scoring System Plus Risk Predicts Post-Transplant Outcomes.
    Samuelson Bannow BT; Salit RB; Storer BE; Stevens EA; Wu D; Yeung C; Fang M; Petersdorf EW; Linenberger ML; Woo J; Sorror ML; Doney K; Sandmaier BM; Deeg HJ; Scott BL
    Biol Blood Marrow Transplant; 2018 Feb; 24(2):386-392. PubMed ID: 28970176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelofibrosis: to transplant or not to transplant?
    Devlin R; Gupta V
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):543-551. PubMed ID: 27913527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.